Bioavailability Study of EVEGYN 600 mg/1000 mg/100 mg Vaginal Ovule

Clinical trial NCT05361369 · COMPLETED

Trial details

NCT number: NCT05361369
Sponsor: Exeltis Turkey
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bioavailability

Start date: 2022-05-09
Primary completion: 2022-05-13
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.